Forty drugs accounted for 69% of Medicare spending for drugs administered in physician and hospital outpatient settings last year, according to an updated dashboard released today by the Centers for Medicare & Medicaid Services. Six of the drugs accounted for more than $1 billion each in Part B spending, CMS said. The dashboard looks at Part B and D drugs with the highest cost increases or spending in 2015. Ten Part D drugs and one Part B drug had price increases of more than 100%. CMS also released a new Medicaid drug spending dashboard, which shows 70 drugs accounted for 41% of program spending on outpatient drugs in 2015. The average cost per unit for five of those drugs increased by more than 400%, CMS said.

Related News Articles

Headline
Medicaid enrollment growth slowed to 2.7% in fiscal year 2017 due to slower enrollment related to the Affordable Care Act, a stable economy and states’…
Headline
The Senate Committee on Health, Education, Labor and Pensions today held the second in a series of hearings on the cost of prescription drugs. “We…
Headline
Baxter Healthcare Corp., in coordination with the Food and Drug Administration, has agreed to temporarily import certain intravenous drug products, such…
Headline
President Trump yesterday named Eric Hargan as Acting Secretary of Health and Human Services. Confirmed as HHS deputy secretary last week, Hargan previously…
Headline
The Centers for Medicare & Medicaid Services has approved a Section 1115 Medicaid demonstration waiver allowing West Virginia to expand its benefits…
Headline
Hospitals generally support the proposed cancellation of the cardiac and Surgical Hip and Femur Fracture Treatment bundling program and Comprehensive Care for…